Your browser doesn't support javascript.
loading
Neurochemical Research of LOXBlock-1 and ZnSO4 against Neurodegenerative Damage Induced by Amyloid Beta(1-42).
Hacioglu, Ceyhan; Kar, Fatih; Sahin, Meryem Cansu.
Affiliation
  • Hacioglu C; Department of Biochemistry, Faculty of Pharmacy, Duzce University, Duzce, Turkey. ceyhanhacioglu@duzce.edu.tr.
  • Kar F; Department of Medical Biochemistry, Faculty of Medicine, Duzce University, Duzce, Turkey. ceyhanhacioglu@duzce.edu.tr.
  • Sahin MC; Department of Medical Biochemistry, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Turkey.
Biol Trace Elem Res ; 2023 Oct 23.
Article de En | MEDLINE | ID: mdl-37872362
ABSTRACT
Synaptosomes offer an intriguing ex vivo model system for investigating the molecular mechanisms of neurodegenerative processes. Lipoxygenases significantly affect the course of neurodegenerative diseases. Homeostasis of trace elements such as zinc is necessary for the continuity of brain functions. In this study, we purpose to determine whether LOXBlock-1, a 12/15 lipoxygenase inhibitor, and zinc sulfate (ZnSO4) provide any biochemical protection during neurodegenerative damage in synaptosomes induced by amyloid beta 1-42 (Aß1-42). In this study, animals (30 Wistar Albino male rats 30) were divided into 5 groups (6 animals in each group) Control, 10µM Aß1-42, 10µM Aß1-42+25mM LOXBlock-1, 10µM Aß1-42+10µM ZnSO4, and 10µM Aß1-42+25mM LOXBlock-1+10µM ZnSO4. Synaptosomes were isolated from the rat cerebral cortex. Following, 8-hydroxy-2-deoxyguanosine (8-OHdG) levels, malondialdehyde (MDA) levels, adenosine deaminase (ADA) levels, reduced-glutathione (GSH) levels, neuronal nitric oxide synthase (nNOS) levels, acetylcholinesterase (AChE) activity, catalase (CAT) activity, and 8-OHdG levels in synaptosomes were detected according to the ELISA method. ADA and AChE expression and protein levels were analyzed. MDA, nNOS, AChE, and 8-OHdG levels in synaptosomes treated with Aß1-42 resulted in an increase, while there was a decrease in ADA, GSH, and CAT levels (p<0.001 vs. control). Conversely, LOXBlock-1 and ZnSO4 treatments in synaptosomes treated with Aß1-42 decreased MDA, nNOS, AChE, and 8-OHdG levels, while ADA, GSH, and CAT levels increased. Moreover, the most effective improvement was seen in the co-treatment group of LOXBlock-1 and ZnSO4. Our data showed that LOXBlock-1 and ZnSO4 co-treatment may protect against Aß1-42 exposure in rat brain synaptosomes.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Biol Trace Elem Res Année: 2023 Type de document: Article Pays d'affiliation: Turquie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Biol Trace Elem Res Année: 2023 Type de document: Article Pays d'affiliation: Turquie